Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

16.87
Delayed Data
As of 4:00pm ET
 +0.04 / +0.24%
Today’s Change
14.07
Today|||52-Week Range
17.40
+4.98%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close16.83
Today’s open16.81
Day’s range16.77 - 16.92
Volume574,792
Average volume (3 months)880,338
Market cap$4.4B
Dividend yield3.25%
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.34-1.32%
PTHNPatheon NV-0.27-0.97%
AGNPRAAllergan plc-15.86-2.03%
OPKOPKO Health Inc-0.11-1.26%
Data as of 4:03pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts


Search for Jobs